Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (51-60 of 324) with videos related to

Pageof 33
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2008
Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitroHeidi G W Lim, Kazuo Suzuki, David A Cooper, et al.
Antiviral Therapy|April 28, 2006
Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adultsMatthew Law, Rebekah Puls, Andrew K Cheng, et al.
Current HIV Research|July 16, 2009
Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolismKatherine Samaras, Handan Wand, Matthew Law, et al.
Marine Pollution Bulletin|August 6, 2003
Latest update of tests and improvements to US Coast Guard viscous oil pumping systemMichael D Drieu, Peter C Nourse, Ronald MacKay, et al.
AIDS (London, England)|December 4, 2004
The HIV Netherlands Australia Thailand research collaboration: lessons from 7 years of clinical researchKelly Safreed-Harmon, David A Cooper, Joep M A Lange, et al.
AIDS (London, England)|November 14, 2014
Comparison of central and local HIV-1 RNA quantification from two international clinical trialsJanaki Amin, Matthew G Law, Rebekah Puls, et al.
AIDS (London, England)|February 9, 2002
The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapyGilbert R Kaufmann, Mark Bloch, Robert Finlayson, et al.
AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.
AIDS (London, England)|January 31, 2018
High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 yearsChelsea N McMahon, Kathy Petoumenos, Karl Hesse, et al.
Lancet (London, England)|July 29, 2008
Relation between HIV viral load and infectiousness: a model-based analysisDavid P Wilson, Matthew G Law, Andrew E Grulich, et al.
Pageof 33

Showing results (51-60 of 324) with videos related to

Sort By:
Pageof 33
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2008
Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitroHeidi G W Lim, Kazuo Suzuki, David A Cooper, et al.
Antiviral Therapy|April 28, 2006
Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adultsMatthew Law, Rebekah Puls, Andrew K Cheng, et al.
Current HIV Research|July 16, 2009
Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolismKatherine Samaras, Handan Wand, Matthew Law, et al.
Marine Pollution Bulletin|August 6, 2003
Latest update of tests and improvements to US Coast Guard viscous oil pumping systemMichael D Drieu, Peter C Nourse, Ronald MacKay, et al.
AIDS (London, England)|December 4, 2004
The HIV Netherlands Australia Thailand research collaboration: lessons from 7 years of clinical researchKelly Safreed-Harmon, David A Cooper, Joep M A Lange, et al.
AIDS (London, England)|November 14, 2014
Comparison of central and local HIV-1 RNA quantification from two international clinical trialsJanaki Amin, Matthew G Law, Rebekah Puls, et al.
AIDS (London, England)|February 9, 2002
The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapyGilbert R Kaufmann, Mark Bloch, Robert Finlayson, et al.
AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.
AIDS (London, England)|January 31, 2018
High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 yearsChelsea N McMahon, Kathy Petoumenos, Karl Hesse, et al.
Lancet (London, England)|July 29, 2008
Relation between HIV viral load and infectiousness: a model-based analysisDavid P Wilson, Matthew G Law, Andrew E Grulich, et al.
Pageof 33